Lokomat Treadmill Training Effects on MS Gait

CompletedNot a drug-phase studyMS (type not specified)NCT00835835

What it found

No results found

We found no results in the registry or in papers.

This trial finished 15 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Body-weight supported treadmill training +/- Lokomat assistance

Placebo

  • Usual Care - no active intervention

What it measured

Main measures

  • Gait Parameters

    Baseline, throughout study enrollment and 2 months follow-up

    Walking and mobility

Who could take part

MS (type not specified) · 25 to 60 · EDSS 3.5 to 6.0

Show the full criteria

Inclusion criteria

Main Inclusion Criteria: * Clinical diagnosis of MS * EDSS level between 3.5-6.0 * Problems with ambulation * able to ambulate 25 feet without an assistive device Main Exclusion Criteria: * Lower extremity injuries that limit range of motion or function * Unable to demonstrate an understanding of the process of the study and or fully understand instructions in order to safely participate in the study and use study equipment * Body weight over 150 kg * complete inclusion/exclusion criteria listed in consent form

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This study is being done to test the possible benefits of gait-specific training using body-weight supported, Lokomat assisted, treadmill training in people with Multiple Sclerosis.

Papers

Loading reviews and guidelines…

History

    1. Started

      Feb 2008

    2. Main results due

      Oct 2011

    3. Finished

      Jun 2013

    Assembled by software from public sources.